R. Müller

Pharmaceutical Science · International journal of pharmaceutics · 2000–2013

A researcher in the Science corpus: 14 papers; trusts 5 researchers and is trusted by 48 researchers here, as inferred from the citation graph.

Subfields

Pharmaceutical Science — 28 citations into it; #1 of 142 by trust here, #1 by citations
Biomaterials — 16 citations into it; #1,329 of 2,152 by trust here, #646 by citations
Molecular Biology — 11 citations into it; #1,205 of 17,773 by trust here, #3,296 by citations
Food Science — 6 citations into it; #114 of 1,700 by trust here, #67 by citations
Organic Chemistry — 6 citations into it

Whom R. Müller trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts R. Müller overall

Papers from R. Müller's perspective

Ordered by how strongly the researchers R. Müller trusts endorse each paper. Same corpus, a different order for every researcher.

Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. (International journal of pharmaceutics)
Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. (Angewandte Chemie)
Nanosizing: a formulation approach for poorly-water-soluble compounds. (European Journal of Pharmaceutical Sciences)
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. (Advanced Drug Delivery Reviews)
Polymer microspheres for controlled drug release. (International journal of pharmaceutics)
Novel injectable neutral solutions of chitosan form biodegradable gels in situ. (Biomaterials)
Nanotechnology: Intelligent Design to Treat Complex Disease (Pharmaceutical Research)

Their papers

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. (2000) — 3,522 citations
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. (2006) — 1,083 citations
Nanostructured lipid matrices for improved microencapsulation of drugs. (2002) — 1,100 citations
Solid lipid nanoparticles for parenteral drug delivery. (2004) — 1,432 citations
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. (2004) — 703 citations
Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. (2013) — 481 citations
State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. (2011) — 652 citations
Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. (2010) — 720 citations
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. (2009) — 1,408 citations
Nanocrystal technology, drug delivery and clinical applications (2008) — 972 citations
Nanostructured lipid carriers (NLC) in cosmetic dermal products. (2007) — 704 citations
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. (2002) — 2,006 citations
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (2001) — 1,441 citations
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. (2000) — 1,590 citations